Title : The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder.

Pub. Date : 2016 Jun

PMID : 27310943






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Significant differences in triglyceride change were associated with the DRD3 Ser9Gly genotype (P = 0.03). Triglycerides dopamine receptor D3 Homo sapiens
2 However, the associations between the DRD3 Ser9Gly polymorphism with changes in triglyceride level become nonsignificant after correcting for multiple comparisons.We conclude that the DRD3 Ser9Gly polymorphism is nominally associated with changes in triglycerides and metabolic syndrome after 12 weeks of standard BDII treatment. Triglycerides dopamine receptor D3 Homo sapiens
3 However, the associations between the DRD3 Ser9Gly polymorphism with changes in triglyceride level become nonsignificant after correcting for multiple comparisons.We conclude that the DRD3 Ser9Gly polymorphism is nominally associated with changes in triglycerides and metabolic syndrome after 12 weeks of standard BDII treatment. Triglycerides dopamine receptor D3 Homo sapiens
4 However, the associations between the DRD3 Ser9Gly polymorphism with changes in triglyceride level become nonsignificant after correcting for multiple comparisons.We conclude that the DRD3 Ser9Gly polymorphism is nominally associated with changes in triglycerides and metabolic syndrome after 12 weeks of standard BDII treatment. Triglycerides dopamine receptor D3 Homo sapiens
5 However, the associations between the DRD3 Ser9Gly polymorphism with changes in triglyceride level become nonsignificant after correcting for multiple comparisons.We conclude that the DRD3 Ser9Gly polymorphism is nominally associated with changes in triglycerides and metabolic syndrome after 12 weeks of standard BDII treatment. Triglycerides dopamine receptor D3 Homo sapiens